TD Cowen: 'Moonlake Immunotherapeutics (MLTX) is a Europe Best Idea' Mar 12, 2025 11:30AM
MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update Feb 26, 2025 07:00AM
TD Cowen Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX) Sep 12, 2024 08:55AM
Cowen Starts Moonlake Immunotherapeutics (MLTX) at Outperform Jul 7, 2022 05:31AM
Helix Acquisition Corp (HLXA) Announces Merger Agreement with MoonLake Immunotherapeutics AG Oct 4, 2021 07:06AM